Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $166 million. The company expects the full year’s ...
Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now ...
10x Genomics, Inc. (NASDAQ:TXG) Q4 2025 Earnings Call Transcript February 12, 2026 10x Genomics, Inc. beats earnings ...
AZoLifeSciences on MSN
SeekGene joins Human Cell Atlas Consortium to advance multiomics research
SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results